OpenVSafe by OpenVAERS
Search V-safe

NBC-13581-13666

1 vaccination 5 coded responses 7 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
799 / TX
Registered
2021-01-18
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-13
    Dose 1 — Moderna
  2. 2021-01-18
    Registered in v-safe
  3. 2021-01-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Fatigue — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Fatigued the first 24 hrs
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-20
    Survey response — day 7, dose 1
    MedDRA: Chest discomfort — Feeling: Fair
    Free text: Chest tightness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-27
    Survey response — day 14, dose 1
    MedDRA: Dyspnoea — Feeling: Good
    Free text: Occasional shortness of breath
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-03
    Survey response — day 21, dose 1
    MedDRA: Dyspnoea, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Occasionally shortness of breath that requires inhaler use for about a day
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-14
    Survey response — 3 months, dose 1
    MedDRA: Asthenia, Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Occasional fatigue and weakness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-14
    Report sent to call center — 3 months, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-07-17
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-13Moderna

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-18

Systemic reaction (other): Fatigued the first 24 hrs

Release 2 — day 7, dose 1

2021-01-20

Systemic reaction (other): Chest tightness

Release 2 — day 14, dose 1

2021-01-27

Symptoms: Occasional shortness of breath

Release 3 — day 21, dose 1

2021-02-03

Symptoms: Occasionally shortness of breath that requires inhaler use for about a day

Release 7 — 3 months, dose 1

2021-04-14

Symptoms: Occasional fatigue and weakness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SROChest discomfort ✓ ✓ ✓
SROFatigue ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release